April 24, 2009… diagnosed with Type 1 diabetes
October 21, 2011… first seizure as a result of hypoglycemia (low blood sugar)
January 26, 2012… second seizure as a result of hypoglycemia
March 31, 2018… Many of you have heard this story a million times. I have Type 1 diabetes (T1D). It’s an autoimmune disorder where I must inject myself with insulin on a daily basis to live. I’m lucky to be alive. I’m lucky this is something I can manage.
And yet part of the story you probably haven’t heard is how research and technology saved my life. In the span of four months back in 2011 and 2012, I experienced two seizures – one at the Baltimore/Washington International Airport and another at the Orlando International Airport (at least I’m consistent). I’m not only thankful for the TSA officials, EMTs and strangers who looked out for me on days when my troubles could have easily been dismissed, but I am thankful I had these experiences.
Because they led me to Gizmo. Continue reading
“I imagine being diagnosed as an adult would be harder because you remember life without it.”
“Yeah.” I nodded at the woman to my left, mother to an 11-year-old with Type 1 diabetes (T1D).
We were both first-timers to the JDRF TypeOneNational 2015 DC Research Summit yesterday. While many parents of children with diabetes attended the day-long event, I was among some of the adults who had been managing this disease for years.
I’m about to celebrate my sixth anniversary with this disease, one year closer to a decade. It’s hard to believe I’ve been managing the disease this long – it’s even harder to believe that I have many years to go. But like speaker Tom Brobson, national director of research investment opportunities at JDRF, reminded us, if we had all been diagnosed one hundred years ago, we wouldn’t have survived a month.
I’d like to believe on the starvation diet I would have lasted a little longer, but he was right about one thing – we’ve come a long way technology-wise. And for that I am thankful. William Tamborlane, chief of pediatric endocrinology at Yale University and deputy director of the Yale Center for Clinical Investigation, familiarized us with the “blue brick,” the first insulin pump device introduced in 1979. It would take another 20 years before the insulin pump would actually take off.
And Jessica Roth, senior director of health policy at JDRF, reminded us of the importance of advocacy. It’s not enough to have all these research advances such as ViaCyte, Smart Insulin, and the artificial pancreas without the ability for people living with this disease to have access to these treatments. It still pains me that Medicare refuses to cover the continuous glucose monitoring (CGM) system for those over 65. Continue reading